Sg3 Management, LLC Kura Oncology, Inc. Call Options Transaction History

Sg3 Management, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$11.78 - $16.98 $848,160 - $1.22 Million	-72,000 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$12.22 - $19.57 $122,200 - $195,700	-10,000 Reduced 12.2%	72,000 $1.01 Million
Q3 2021 Nov 15, 2021	BUY	$15.42 - $21.72 $724,740 - $1.02 Million	47,000 Added 134.29%	82,000 $1.54 Million
Q2 2021 Aug 16, 2021	BUY	$20.85 - $29.88 $729,750 - $1.05 Million	35,000 New	35,000 $730,000
Q1 2021 May 17, 2021	SELL	$24.75 - $39.14 $381,150 - $602,756	-15,400 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$29.0 - $41.62 $107,300 - $153,994	3,700 Added 31.62%	15,400 $503,000
Q3 2020 Nov 13, 2020	BUY	$16.3 - $30.64 $190,710 - $358,488	11,700 New	11,700 $358,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $738M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.